Portola Pharmaceuticals, Inc. (PTLa)
Rep. Lamar Smith disclosed that the filer purchased · $1,001 – $15,000
View transaction source status →Traded Jan 2, 2019Notified Jan 8, 2019Filed Jan 10, 20198 days to file
Owner: FilerView original filing →
Issuer disclosure record
$PTLA
Company name unavailable
Transactions involving this ticker in readable 2013–2026 House reports. This page describes disclosure activity, not the issuer’s performance and not a recommendation to trade.
2
Purchases
0
Sales
1
Filers
2
Reports
Transaction history
Who disclosed trading $PTLA?
HaRES oF PRaXaIR EXCHaNgEd FoR 56 SHaRES oF LINdE PLC. CoMMENTS: LINdE PLC CoMbINEd LINdE ag WITH PRaXaIR oN oCTobER 31,2018. aLL PRaXaIR SToCK EXCHaNgEd FoR LINdE PLC SToCK. (oNE SHaRE FoR oNE SHaRE). SToCK VaLUE IS CoST baSIS IN PRaXaIR. Portola Pharmaceuticals, Inc. (PTLa)
Rep. Lamar Smith disclosed that the filer purchased · $1,001 – $15,000
View transaction source status →Traded Oct 3, 2018Notified Nov 7, 2018Filed Nov 8, 201836 days to file
Owner: FilerView original filing →